Cancer Research  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 58, 711-716, February 15, 1998]
© 1998 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barthelman, M.
Right arrow Articles by Bowden, G. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barthelman, M.
Right arrow Articles by Bowden, G. T.

Inhibitory Effects of Perillyl Alcohol on UVB-induced Murine Skin Cancer and AP-1 Transactivation1

Margaret Barthelman, Weixing Chen, Helen L. Gensler, Chuanshu Huang, Zigang Dong and G. Tim Bowden2

Department of Radiation Oncology, The University of Arizona Health Sciences Center, Tucson, Arizona 85724 [M. B., W. C., H. L. G., G. T. B.], and The Hormel Institute, University of Minnesota, Austin, Minnesota 55912 [C. H., Z. D.]

The monoterpene perillyl alcohol (POH) has proven efficacious against the formation and progression of a variety of cancers. In this study, we tested the ability of POH to inhibit photocarcinogenesis in a nonmelanoma model of mouse skin carcinogenesis and its ability to inhibit UVB-induced activator protein 1 (AP-1) transactivation in mouse skin and human keratinocytes. POH (10 mM) was applied topically to the ears and shaved dorsal surface of groups of 35 BALB/c mice throughout the experiment, during and after UVB treatment. Topical POH significantly inhibited tumor incidence and multiplicity, average tumor size, and the average tumor burden/mouse without any apparent toxicity. POH inhibited UVB-induced AP-1 transactivation in both cultured human keratinocytes and transgenic mice that stably express a luciferase reporter driven by AP-1 elements. The results suggest that POH might be used for chemoprevention of human skin cancer, and that inhibition of AP-1 activity is functionally related to inhibition of skin carcinogenesis.

1 Supported by NIH Grant CA-27502.

2 To whom requests for reprints should be addressed, at Department of Radiation Oncology, The University of Arizona Health Sciences Center, 1515 North Campbell Avenue, Tucson, AZ 85724. Phone: (520) 626-6006; Fax: (520) 626-4480.

Received 9/12/97. Accepted 12/16/97.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
A. Charruyer, S. Grazide, C. Bezombes, S. Muller, G. Laurent, and J.-P. Jaffrezou
UV-C Light Induces Raft-associated Acid Sphingomyelinase and JNK Activation and Translocation Independently on a Nuclear Signal
J. Biol. Chem., May 13, 2005; 280(19): 19196 - 19204.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
M. A. Bachelor, S. J. Cooper, E. T. Sikorski, and G. T. Bowden
Inhibition of p38 Mitogen-Activated Protein Kinase and Phosphatidylinositol 3-Kinase Decreases UVB-Induced Activator Protein-1 and Cyclooxygenase-2 in a SKH-1 Hairless Mouse Model
Mol. Cancer Res., February 1, 2005; 3(2): 90 - 99.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
Y.-K. Won, C.-N. Ong, X. Shi, and H.-M. Shen
Chemopreventive activity of parthenolide against UVB-induced skin cancer and its mechanisms
Carcinogenesis, August 1, 2004; 25(8): 1449 - 1458.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. S. Clark, L. Zhong, D. Filiault, S. Perman, Z. Ren, M. Gould, and X. Yang
Anti-Leukemia Effect of Perillyl Alcohol in Bcr/Abl-Transformed Cells Indirectly Inhibits Signaling through Mek in a Ras- and Raf-Independent Fashion
Clin. Cancer Res., October 1, 2003; 9(12): 4494 - 4504.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
B. W. Liston, R. Nines, P. S. Carlton, A. Gupta, R. Aziz, W. Frankel, and G. D. Stoner
Perillyl Alcohol as a Chemopreventive Agent in N-Nitrosomethylbenzylamine-induced Rat Esophageal Tumorigenesis
Cancer Res., May 15, 2003; 63(10): 2399 - 2403.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
M.-F. Demierre and L. Nathanson
Chemoprevention of Melanoma: An Unexplored Strategy
J. Clin. Oncol., January 1, 2003; 21(1): 158 - 165.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. Lluria-Prevatt, J. Morreale, J. Gregus, D. S. Alberts, F. Kaper, A. Giaccia, and M. B. Powell
Effects of Perillyl Alcohol on Melanoma in the TPras Mouse Model
Cancer Epidemiol. Biomarkers Prev., June 1, 2002; 11(6): 573 - 579.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
G. Liu, A. Bode, W.-Y. Ma, S. Sang, C.-T. Ho, and Z. Dong
Two Novel Glycosides from the Fruits of Morinda Citrifolia (Noni) Inhibit AP-1 Transactivation and Cell Transformation in the Mouse Epidermal JB6 Cell Line
Cancer Res., August 1, 2001; 61(15): 5749 - 5756.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Chen, M. Nomura, Q.-B. She, W.-Y. Ma, A. M. Bode, L. Wang, R. A. Flavell, and Z. Dong
Suppression of Skin Tumorigenesis in c-Jun NH2-Terminal Kinase-2-Deficient Mice
Cancer Res., May 1, 2001; 61(10): 3908 - 3912.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
S. Zhong, J. A. Quealy, A. M. Bode, M. Nomura, A. Kaji, W.-Y. Ma, and Z. Dong
Organ-specific Activation of Activator Protien-1 in Transgenic Mice by 12-O-Tetradecanoylphorbol-13-acetate with Different Administration Methods
Cancer Res., May 1, 2001; 61(10): 4084 - 4091.
[Abstract] [Full Text]


Home page
CarcinogenesisHome page
A. Gupta, S. F. Rosenberger, and G. T. Bowden
Increased ROS levels contribute to elevated transcription factor and MAP kinase activities in malignantly progressed mouse keratinocyte cell lines
Carcinogenesis, November 1, 1999; 20(11): 2063 - 2073.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
K. Kramer-Stickland, A. Edmonds, W. B. Bair III, and G.T. Bowden
Inhibitory effects of deferoxamine on UVB-induced AP-1 transactivation
Carcinogenesis, November 1, 1999; 20(11): 2137 - 2142.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Ding, X. Shi, Z. Dong, F. Chen, Y. Lu, V. Castranova, and V. Vallyathan
Freshly Fractured Crystalline Silica Induces Activator Protein-1 Activation through ERKs and p38 MAPK
J. Biol. Chem., October 22, 1999; 274(43): 30611 - 30616.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Ding, Z. Dong, F. Chen, D. Pack, W.-Y. Ma, J. Ye, X. Shi, V. Castranova, and V. Vallyathan
Asbestos Induces Activator Protein-1 Transactivation in Transgenic Mice
Cancer Res., April 1, 1999; 59(8): 1884 - 1889.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. Chen, A. H. Borchers, Z. Dong, M. B. Powell, and G. T. Bowden
UVB Irradiation-induced Activator Protein-1 Activation Correlates with Increased c-fos Gene Expression in a Human Keratinocyte Cell Line
J. Biol. Chem., November 27, 1998; 273(48): 32176 - 32181.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Ding, X. Shi, Y. Lu, C. Huang, S. Leonard, J. Roberts, J. Antonini, V. Castranova, and V. Vallyathan
Induction of Activator Protein-1 through Reactive Oxygen Species by Crystalline Silica in JB6 Cells
J. Biol. Chem., March 16, 2001; 276(12): 9108 - 9114.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1998 by the American Association for Cancer Research.